Effects of the Angiotensin Receptor Blocker Candesartan on Arterial Stiffness and Markers of Extracellular Matrix Metabolism in Patients with Essential Hypertension.
From: Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. sasamura@sc.itc.keio.ac.jp
Clinical and experimental hypertension (New York, N.Y. : 1993)
- Publish Date: Jul 2006
- ISSN: 1064-1963
- Volume: 28
- Issue: 5
- Pages: 511-20
- Medium: Print
- Language: English
- Citation (JAMA): Sasamura Hiroyuki, Kitamura Yudai, Nakamura Mari, et al. Effects of the Angiotensin Receptor Blocker Candesartan on Arterial Stiffness and Markers of Extracellular Matrix Metabolism in Patients with Essential Hypertension.. Clin. Exp. Hypertens. Jul 2006;28:511-20
Abstract
Laboratory studies have shown that angiotensin receptor blockers (ARBs) can affect extracellular matrix (ECM) metabolism and thereby have a beneficial effect on vascular remodeling. The aim of this study was to examine the clinical effects of the ARB candesartan cilexetil on serum markers of synthesis and degradation of ECM, as well as their relation to changes in arterial stiffness in hypertensive patients. Twenty-three patients with essential hypertension were recruited for this study. Markers related to ECM synthesis and degradation (procollagen type 1 propeptide [PIP], procollagen type III propeptide [PIIIP], matrix metalloproteinase-3 [MMP-3, stromelysin-1], tissue inhibitor of matrix metalloproteinases [TIMP-1], and hyaluronic acid [HA]) were examined both before and after one year of treatment with candesartan. Pulse-wave velocity [PWV] and ankle-brachial pressure index [ABI] were measured two months (i.e., after achieving blood pressure reduction) and one year after the initiation of therapy. PWV values after one year of treatment with ARB were significantly decreased compared to previous values, whereas ABI values were unchanged. Treatment with ARB was also associated with a significant decrease in serum PIIIP values and an increase in serum stromelysin-1, whereas changes in PIP, TIMP-1, and HA did not achieve statistical significance. A significant relationship was found between the changes in PWV and the changes in stromelysin-1 levels after correction for blood pressure and heart rate (p = 0.02). These results suggest that the treatment for just one year with ARB results in significant changes in markers of ECM metabolism as well as PWV. These effects on ECM metabolism could have a beneficial effect in decreasing vascular pathology in patients with essential hypertension.
Mesh Headings (Keywords): Angiotensin II Type 1 Receptor Blockers, Antihypertensive Agents, Benzimidazoles, Biological Markers, Biphenyl Compounds, Blood Flow Velocity, Blood Pressure, Extracellular Matrix, Female, Heart Rate, Humans, Hyaluronic Acid, Hypertension, Male, Matrix Metalloproteinase 3, Middle Aged, Peptide Fragments, Procollagen, Tetrazoles, Time Factors, Tissue Inhibitor of Metalloproteinase-1, Treatment Outcome, Vascular Resistance
Check for Full Text / PubMed Unique Identifier (PMID): 16820347
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.